Compare Nuwellis Inc (NUWE) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while iShares 10 20 Year Treasury Bond ETF trades at $92.19 (market cap $11.02B). The key difference: iShares 10 20 Year Treasury Bond ETF is far larger — about 5009.1× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 6,609,157). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and iShares 10 20 Year Treasury Bond ETF for 60 Days on average.
| NUWE | TLH | |
|---|---|---|
Market Cap | $2.20M | $11.02B |
Volume | 121,544 | 6,609,157 |
Sector | Health | Fixed Income |
52-Week High | $146.65 | $105.36 |
52-Week Low | $0.68 | $91.34 |
Typical Hold Time | 26 Days | 60 Days |
Enterprise Value | -$1.52M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
TLH (iShares 10-20 Year Treasury Bond ETF) trades at $92.11, up 0.72% with bearish technical signals from moving averages. The ETF shows unusually high trading volume, up 66% recently, amid a challenging bond market environment where 10-year Treasury yields have reached multi-decade highs. Recent dividend payments of $0.36-$0.38 reflect the fund's income-generating nature.
Outlook remains cautious as rising bond yields pressure long-term Treasury ETFs. Investment opportunity exists for income-focused investors seeking regular dividends, but risks include continued yield increases and Federal Reserve policy uncertainty. The bearish technical picture suggests near-term pressure on bond ETF valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
